Bexarotene Modulates Retinoid-X-Receptor Expression and Is Protective Against Neurotoxic Endoplasmic Reticulum Stress Response and Apoptotic Pathway Activation

Retinoid X-receptors (RXRs) are members of the ligand-dependent transcription factor family of nuclear receptors that have gained recent research focus as potential targets for neurodegenerative disorders. Bexarotene is an RXR pharmacological agonist that is shown to be neuroprotective through its e...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Molecular neurobiology Ročník 55; číslo 12; s. 9043 - 9056
Hlavní autori:	Dheer, Yogita, Chitranshi, Nitin, Gupta, Veer, Abbasi, Mojdeh, Mirzaei, Mehdi, You, Yuyi, Chung, Roger, Graham, Stuart L., Gupta, Vivek
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	New York Springer US 01.12.2018 Springer Nature B.V
Predmet:	Alzheimer Disease - drug therapy Alzheimer Disease - metabolism Alzheimer Disease - pathology Amyloid beta-Peptides - metabolism Animals Apoptosis Apoptosis - drug effects Bad protein bcl-Associated Death Protein - metabolism Bexarotene - pharmacology Bexarotene - therapeutic use Biomedical and Life Sciences Biomedicine Cell Biology Cell Line, Tumor Cell Survival - drug effects Disease Models, Animal Endoplasmic reticulum Endoplasmic Reticulum Stress - drug effects Glial cells Heat shock proteins Humans Immunofluorescence Isoforms Male Mice, Inbred C57BL Neurobiology Neuroblasts Neurodegenerative diseases Neurology Neuroprotection Neuroprotection - drug effects Neurosciences Neurotoxicity Neurotoxicity Syndromes - drug therapy Neurotoxicity Syndromes - metabolism Neurotoxicity Syndromes - pathology Nuclear receptors Receptor, trkB - metabolism Retinoid X receptors Retinoid X Receptors - metabolism Signal transduction Stress response Therapeutic applications Therapeutic targets TrkB receptors Up-Regulation - drug effects Western blotting ER stress Retinoid-X-receptor Bexarotene TrkB Amyloid beta
ISSN:	0893-7648, 1559-1182, 1559-1182
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Retinoid X-receptors (RXRs) are members of the ligand-dependent transcription factor family of nuclear receptors that have gained recent research focus as potential targets for neurodegenerative disorders. Bexarotene is an RXR pharmacological agonist that is shown to be neuroprotective through its effects in promoting amyloid beta (Aβ) uptake by the glial cells in the brain. This study aimed to evaluate the dose-dependent effects of bexarotene on RXR expression in SH-SY5Y neuroblastoma cells and validate the drug effects in the brain in vivo. The protein expression studies were carried out using a combination of various drug treatment paradigms followed by expression analysis using Western blotting and immunofluorescence. Our study demonstrated that bexarotene promoted the expression of RXR α, β and γ isoforms at optimal concentrations in the cells and in the mice brain. Interestingly, a decreased RXR expression was identified in Alzheimer’s disease mouse model and in the cells that were treated with Aβ. Bexarotene treatment not only rescued the RXR expression loss caused by Aβ treatment ( p < 0.05) but also protected the cells against Aβ-induced ER stress ( p < 0.05) and pro-apoptotic BAD protein activation ( p < 0.05). In contrast, higher concentrations of bexarotene upregulated the ER stress proteins and led to BAD activation. Our study revealed that these downstream neurotoxic effects of high drug concentrations could be prevented by pharmacological targeting of the TrkB receptor. The ER stress and BAD activation induced by high concentrations of bexarotene were rescued by the TrkB agonist, 7,8 dihydroxyflavone ( p < 0.05) while TrkB inhibitor CTX-B treatment further exacerbated these effects. Together, these findings suggest a cross-talk of TrkB signalling with downstream effects of bexarotene toxicity and indicate that therapeutic targeting of RXRs could prevent the Aβ-induced molecular neurotoxic effects.
AbstractList	Retinoid X-receptors (RXRs) are members of the ligand-dependent transcription factor family of nuclear receptors that have gained recent research focus as potential targets for neurodegenerative disorders. Bexarotene is an RXR pharmacological agonist that is shown to be neuroprotective through its effects in promoting amyloid beta (Aβ) uptake by the glial cells in the brain. This study aimed to evaluate the dose-dependent effects of bexarotene on RXR expression in SH-SY5Y neuroblastoma cells and validate the drug effects in the brain in vivo. The protein expression studies were carried out using a combination of various drug treatment paradigms followed by expression analysis using Western blotting and immunofluorescence. Our study demonstrated that bexarotene promoted the expression of RXR α, β and γ isoforms at optimal concentrations in the cells and in the mice brain. Interestingly, a decreased RXR expression was identified in Alzheimer’s disease mouse model and in the cells that were treated with Aβ. Bexarotene treatment not only rescued the RXR expression loss caused by Aβ treatment ( p < 0.05) but also protected the cells against Aβ-induced ER stress ( p < 0.05) and pro-apoptotic BAD protein activation ( p < 0.05). In contrast, higher concentrations of bexarotene upregulated the ER stress proteins and led to BAD activation. Our study revealed that these downstream neurotoxic effects of high drug concentrations could be prevented by pharmacological targeting of the TrkB receptor. The ER stress and BAD activation induced by high concentrations of bexarotene were rescued by the TrkB agonist, 7,8 dihydroxyflavone ( p < 0.05) while TrkB inhibitor CTX-B treatment further exacerbated these effects. Together, these findings suggest a cross-talk of TrkB signalling with downstream effects of bexarotene toxicity and indicate that therapeutic targeting of RXRs could prevent the Aβ-induced molecular neurotoxic effects. Retinoid X-receptors (RXRs) are members of the ligand-dependent transcription factor family of nuclear receptors that have gained recent research focus as potential targets for neurodegenerative disorders. Bexarotene is an RXR pharmacological agonist that is shown to be neuroprotective through its effects in promoting amyloid beta (Aβ) uptake by the glial cells in the brain. This study aimed to evaluate the dose-dependent effects of bexarotene on RXR expression in SH-SY5Y neuroblastoma cells and validate the drug effects in the brain in vivo. The protein expression studies were carried out using a combination of various drug treatment paradigms followed by expression analysis using Western blotting and immunofluorescence. Our study demonstrated that bexarotene promoted the expression of RXR α, β and γ isoforms at optimal concentrations in the cells and in the mice brain. Interestingly, a decreased RXR expression was identified in Alzheimer’s disease mouse model and in the cells that were treated with Aβ. Bexarotene treatment not only rescued the RXR expression loss caused by Aβ treatment (p < 0.05) but also protected the cells against Aβ-induced ER stress (p < 0.05) and pro-apoptotic BAD protein activation (p < 0.05). In contrast, higher concentrations of bexarotene upregulated the ER stress proteins and led to BAD activation. Our study revealed that these downstream neurotoxic effects of high drug concentrations could be prevented by pharmacological targeting of the TrkB receptor. The ER stress and BAD activation induced by high concentrations of bexarotene were rescued by the TrkB agonist, 7,8 dihydroxyflavone (p < 0.05) while TrkB inhibitor CTX-B treatment further exacerbated these effects. Together, these findings suggest a cross-talk of TrkB signalling with downstream effects of bexarotene toxicity and indicate that therapeutic targeting of RXRs could prevent the Aβ-induced molecular neurotoxic effects. Retinoid X-receptors (RXRs) are members of the ligand-dependent transcription factor family of nuclear receptors that have gained recent research focus as potential targets for neurodegenerative disorders. Bexarotene is an RXR pharmacological agonist that is shown to be neuroprotective through its effects in promoting amyloid beta (Aβ) uptake by the glial cells in the brain. This study aimed to evaluate the dose-dependent effects of bexarotene on RXR expression in SH-SY5Y neuroblastoma cells and validate the drug effects in the brain in vivo. The protein expression studies were carried out using a combination of various drug treatment paradigms followed by expression analysis using Western blotting and immunofluorescence. Our study demonstrated that bexarotene promoted the expression of RXR α, β and γ isoforms at optimal concentrations in the cells and in the mice brain. Interestingly, a decreased RXR expression was identified in Alzheimer's disease mouse model and in the cells that were treated with Aβ. Bexarotene treatment not only rescued the RXR expression loss caused by Aβ treatment (p < 0.05) but also protected the cells against Aβ-induced ER stress (p < 0.05) and pro-apoptotic BAD protein activation (p < 0.05). In contrast, higher concentrations of bexarotene upregulated the ER stress proteins and led to BAD activation. Our study revealed that these downstream neurotoxic effects of high drug concentrations could be prevented by pharmacological targeting of the TrkB receptor. The ER stress and BAD activation induced by high concentrations of bexarotene were rescued by the TrkB agonist, 7,8 dihydroxyflavone (p < 0.05) while TrkB inhibitor CTX-B treatment further exacerbated these effects. Together, these findings suggest a cross-talk of TrkB signalling with downstream effects of bexarotene toxicity and indicate that therapeutic targeting of RXRs could prevent the Aβ-induced molecular neurotoxic effects.Retinoid X-receptors (RXRs) are members of the ligand-dependent transcription factor family of nuclear receptors that have gained recent research focus as potential targets for neurodegenerative disorders. Bexarotene is an RXR pharmacological agonist that is shown to be neuroprotective through its effects in promoting amyloid beta (Aβ) uptake by the glial cells in the brain. This study aimed to evaluate the dose-dependent effects of bexarotene on RXR expression in SH-SY5Y neuroblastoma cells and validate the drug effects in the brain in vivo. The protein expression studies were carried out using a combination of various drug treatment paradigms followed by expression analysis using Western blotting and immunofluorescence. Our study demonstrated that bexarotene promoted the expression of RXR α, β and γ isoforms at optimal concentrations in the cells and in the mice brain. Interestingly, a decreased RXR expression was identified in Alzheimer's disease mouse model and in the cells that were treated with Aβ. Bexarotene treatment not only rescued the RXR expression loss caused by Aβ treatment (p < 0.05) but also protected the cells against Aβ-induced ER stress (p < 0.05) and pro-apoptotic BAD protein activation (p < 0.05). In contrast, higher concentrations of bexarotene upregulated the ER stress proteins and led to BAD activation. Our study revealed that these downstream neurotoxic effects of high drug concentrations could be prevented by pharmacological targeting of the TrkB receptor. The ER stress and BAD activation induced by high concentrations of bexarotene were rescued by the TrkB agonist, 7,8 dihydroxyflavone (p < 0.05) while TrkB inhibitor CTX-B treatment further exacerbated these effects. Together, these findings suggest a cross-talk of TrkB signalling with downstream effects of bexarotene toxicity and indicate that therapeutic targeting of RXRs could prevent the Aβ-induced molecular neurotoxic effects.
Author	Mirzaei, Mehdi Abbasi, Mojdeh Graham, Stuart L. Chitranshi, Nitin You, Yuyi Chung, Roger Dheer, Yogita Gupta, Veer Gupta, Vivek
Author_xml	– sequence: 1 givenname: Yogita orcidid: 0000-0001-7525-7511 surname: Dheer fullname: Dheer, Yogita email: yogitadheer@gmail.com organization: Faculty of Medicine and Health Sciences, Macquarie University – sequence: 2 givenname: Nitin surname: Chitranshi fullname: Chitranshi, Nitin organization: Faculty of Medicine and Health Sciences, Macquarie University – sequence: 3 givenname: Veer surname: Gupta fullname: Gupta, Veer organization: School of Medical Sciences, Edith Cowan University – sequence: 4 givenname: Mojdeh surname: Abbasi fullname: Abbasi, Mojdeh organization: Faculty of Medicine and Health Sciences, Macquarie University – sequence: 5 givenname: Mehdi surname: Mirzaei fullname: Mirzaei, Mehdi organization: Department of Chemistry and Biomolecular Sciences, Macquarie University – sequence: 6 givenname: Yuyi surname: You fullname: You, Yuyi organization: Save Sight Institute, Sydney University – sequence: 7 givenname: Roger surname: Chung fullname: Chung, Roger organization: Faculty of Medicine and Health Sciences, Macquarie University – sequence: 8 givenname: Stuart L. surname: Graham fullname: Graham, Stuart L. organization: Faculty of Medicine and Health Sciences, Macquarie University, Save Sight Institute, Sydney University – sequence: 9 givenname: Vivek surname: Gupta fullname: Gupta, Vivek organization: Faculty of Medicine and Health Sciences, Macquarie University
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/29637440$$D View this record in MEDLINE/PubMed
BookMark	eNp9kc1u1DAUhS1URKeFB2CDLLFhE_BPEtvLoRqgUoGqgMQucuw7xVVip7YD06fhVXE6BaRKsLJ19Z1zr845Qgc-eEDoKSUvKSHiVaKM8KYiVFaU1LRSD9CKNo2qKJXsAK2IVLwSbS0P0VFKV4QwRol4hA6Zarmoa7JCP1_DTseQwQN-H-w86AwJX0B2Pjhbfa0uwMCUQ8Sb3RQhJRc81t7i04TPF53J7jvg9aV2PmX8AeYyDDtn8MbbMA06jeW_-Jl5mEf8KS8mZZCm4BPcWq2nUDYUAp_r_O2HvsHrxVXnsusxerjVQ4Ind-8x-vJm8_nkXXX28e3pyfqsMjWXuRKNrkUvreqhMYoYRXvGtr0FQ3hLxdZCiUXWDCizPdVWUW6JanoJsm6llPwYvdj7TjFcz5ByN7pkYBi0hzCnjhFWEyoU5wV9fg-9CnP05bqF4o1sJReFenZHzf0ItpuiG3W86X5HXwC6B0wMKUXY_kEo6ZZ6u329Xam3W-rtVNGIexrj8m1OOWo3_FfJ9spUtvhLiH-P_rfoF-GQu1I
CitedBy_id	crossref_primary_10_1038_s41598_022_15348_7 crossref_primary_10_3892_ijmm_2025_5504 crossref_primary_10_1016_j_expneurol_2019_01_015 crossref_primary_10_3390_cells11223665 crossref_primary_10_1007_s12035_019_1512_7 crossref_primary_10_1016_j_bmc_2019_05_045 crossref_primary_10_1016_j_ymthe_2025_08_034 crossref_primary_10_1080_07391102_2021_2021991 crossref_primary_10_1186_s12974_019_1432_5 crossref_primary_10_1016_j_mito_2020_08_003 crossref_primary_10_1016_j_preteyeres_2020_100899 crossref_primary_10_1096_fj_202402642R crossref_primary_10_1016_j_lfs_2024_122892 crossref_primary_10_1002_pmic_202000213 crossref_primary_10_1007_s12035_021_02521_8 crossref_primary_10_1007_s12264_021_00735_3 crossref_primary_10_1161_STROKEAHA_119_027037 crossref_primary_10_1007_s11064_020_03197_7 crossref_primary_10_3389_fphar_2023_1187066 crossref_primary_10_1208_s12249_022_02367_w crossref_primary_10_1016_j_bmcl_2020_127666 crossref_primary_10_3390_ijms26031207 crossref_primary_10_1016_j_arr_2023_102021 crossref_primary_10_1111_ijd_16763 crossref_primary_10_1007_s13346_020_00816_2 crossref_primary_10_1016_j_expneurol_2022_114228 crossref_primary_10_1016_j_jlr_2024_100510 crossref_primary_10_1007_s12035_020_01948_9 crossref_primary_10_1016_j_jphotochem_2023_114881 crossref_primary_10_1007_s12035_021_02709_y
Cites_doi	10.3389/fncel.2015.00250 10.1016/S1474-4422(10)70119-8 10.1523/JNEUROSCI.2252-13.2013 10.1523/JNEUROSCI.1001-15.2015 10.1016/j.bbrc.2012.01.037 10.1093/cercor/bhu105 10.1021/jm00016a018 10.3233/JAD-2011-111037 10.1016/S0166-4328(03)00099-8 10.1097/01.LAB.0000074895.48776.D8 10.1074/jbc.M114.600833 10.1186/1750-1326-8-13 10.1016/j.neurobiolaging.2014.03.029 10.1038/sj.embor.7400779 10.1111/j.1365-2133.2007.07975.x 10.1038/npp.2011.191 10.3109/10428194.2012.656625 10.1515/fobio-2016-0005 10.1038/nrn2738 10.3233/JAD-150469 10.1016/S0083-6729(02)65071-X 10.1186/1750-1326-8-18 10.1002/jcp.20784 10.1007/s12031-012-9899-x 10.1016/j.tem.2010.06.009 10.1038/nm.1912 10.1111/j.1471-4159.2005.03135.x 10.1128/JVI.00626-13 10.1007/s11064-008-9848-9 10.1074/jbc.270.42.24725 10.1038/npp.2013.243 10.1126/science.1233937 10.1001/archderm.141.3.315 10.1126/science.1217697 10.1016/j.neuroscience.2017.09.028 10.1523/JNEUROSCI.5198-13.2014 10.1021/cn400100f 10.1038/srep24048 10.1038/srep33176 10.1101/gad.6.3.329 10.1126/science.1234089 10.1371/journal.pone.0009777 10.1517/14728222.2011.594043 10.1093/brain/awn125 10.1523/JNEUROSCI.4065-07.2008 10.3233/JAD-132720 10.3390/ijms140510122 10.1038/sj.cdd.4401373 10.1002/0471142735.ima03bs111 10.1186/s13195-016-0173-2 10.1016/j.bbrc.2014.10.087 10.1016/S0140-6736(08)61075-2 10.1212/WNL.0b013e318211c352 10.1007/s00018-016-2295-x 10.1126/science.1235809 10.1126/science.1235505 10.1038/ncb0311-184 10.1016/j.bbadis.2014.05.026 10.1016/j.ceca.2005.06.019 10.1016/0092-8674(92)90479-V 10.1016/j.neulet.2016.04.059 10.1016/j.nbd.2004.06.007 10.1523/JNEUROSCI.3153-08.2008 10.1016/j.pharmthera.2007.03.005 10.1101/lm.89805 10.1128/MCB.01097-13 10.1038/srep42270 10.1371/journal.pone.0113397 10.1016/j.neuroimage.2010.06.020 10.1007/s00281-013-0373-9 10.1016/j.pneurobio.2005.03.002 10.1016/j.bbadis.2013.08.007 10.1172/JCI69774 10.1016/S0896-6273(00)80654-6 10.1002/jnr.21292 10.1007/s12031-012-9866-6 10.1016/j.neurobiolaging.2013.10.085
ContentType	Journal Article
Copyright	Springer Science+Business Media, LLC, part of Springer Nature 2018 Molecular Neurobiology is a copyright of Springer, (2018). All Rights Reserved.
Copyright_xml	– notice: Springer Science+Business Media, LLC, part of Springer Nature 2018 – notice: Molecular Neurobiology is a copyright of Springer, (2018). All Rights Reserved.
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QR 7TK 7X7 7XB 88A 88E 88G 88I 8AO 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M2P M7P P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8
DOI	10.1007/s12035-018-1041-9
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Chemoreception Abstracts Neurosciences Abstracts Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest SciTech Premium Collection Natural Science Collection Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Collection (ProQuest) ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Psychology Database (ProQuest) Science Database Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	ProQuest One Psychology MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Anatomy & Physiology
EISSN	1559-1182
EndPage	9056
ExternalDocumentID	29637440 10_1007_s12035_018_1041_9
Genre	Journal Article
GrantInformation_xml	– fundername: National Health and Medical Research Council grantid: 1084767 funderid: http://dx.doi.org/10.13039/501100000925 – fundername: The Ophthalmic Research Institute of Australia grantid: 9201400700 funderid: http://dx.doi.org/10.13039/501100001108 – fundername: National Health and Medical Research Council grantid: 1084767 – fundername: The Ophthalmic Research Institute of Australia grantid: 9201400700
GroupedDBID	--- -4W -56 -5G -BR -EM -Y2 -~C -~X .86 .GJ .VR 06C 06D 0R~ 0VY 123 1N0 2.D 203 28- 29M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 3SX 3V. 4.4 406 408 40D 40E 53G 5VS 67N 6NX 78A 7X7 88A 88E 88I 8AO 8CJ 8FE 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHLI ABHQN ABIVO ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABUWG ABWNU ABXPI ACAOD ACBXY ACCUX ACDTI ACGFS ACGOD ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACZOJ ADBBV ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFGCZ AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AIAKS AIGIU AIIXL AILAN AITGF AIZAD AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBNVY BBWZM BDATZ BENPR BGNMA BHPHI BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP D1J DDRTE DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMOBN ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 H13 HCIFZ HF~ HG6 HMCUK HMJXF HRMNR HVGLF HZ~ IJ- IKXTQ ITM IWAJR IXC I~X I~Z J-C J0Z JBSCW JZLTJ KDC KOV LK8 LLZTM M0L M1P M2M M2P M4Y M7P MA- N2Q N9A NDZJH NF0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OVD P19 P2P PF0 PQQKQ PROAC PSQYO PSYQQ PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W48 WK6 WK8 XJT YLTOR Z7U Z7W Z82 Z83 Z87 Z8O Z8V Z91 ZGI ZMTXR ZOVNA ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFFHD AFHIU AFOHR AGQPQ AHDLI AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 7QR 7TK 7XB 8FD 8FK FR3 K9. P64 PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO
ID	FETCH-LOGICAL-c438t-75a47b8d9be5c90c91b22fbdec03617fde559842e12db1ad913d095b8e8468883
IEDL.DBID	M7P
ISICitedReferencesCount	42
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000448483400020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0893-7648 1559-1182
IngestDate	Fri Sep 05 09:22:35 EDT 2025 Tue Nov 04 22:08:30 EST 2025 Thu Apr 03 07:02:26 EDT 2025 Sat Nov 29 02:25:38 EST 2025 Tue Nov 18 22:37:06 EST 2025 Fri Feb 21 02:38:16 EST 2025
IsPeerReviewed	true
IsScholarly	true
Issue	12
Keywords	ER stress Retinoid-X-receptor Bexarotene TrkB Amyloid beta
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c438t-75a47b8d9be5c90c91b22fbdec03617fde559842e12db1ad913d095b8e8468883
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0001-7525-7511
PMID	29637440
PQID	2023586837
PQPubID	55365
PageCount	14
ParticipantIDs	proquest_miscellaneous_2024017933 proquest_journals_2023586837 pubmed_primary_29637440 crossref_primary_10_1007_s12035_018_1041_9 crossref_citationtrail_10_1007_s12035_018_1041_9 springer_journals_10_1007_s12035_018_1041_9
PublicationCentury	2000
PublicationDate	2018-12-01
PublicationDateYYYYMMDD	2018-12-01
PublicationDate_xml	– month: 12 year: 2018 text: 2018-12-01 day: 01
PublicationDecade	2010
PublicationPlace	New York
PublicationPlace_xml	– name: New York – name: United States – name: Totowa
PublicationTitle	Molecular neurobiology
PublicationTitleAbbrev	Mol Neurobiol
PublicationTitleAlternate	Mol Neurobiol
PublicationYear	2018
Publisher	Springer US Springer Nature B.V
Publisher_xml	– name: Springer US – name: Springer Nature B.V
References	Minichiello (CR28) 2009; 10 Price, Xu, Siemienski, Smithson, Borchelt, Golde, Felsenstein (CR47) 2013; 340 Gupta, You, Gupta, Klistorner, Graham (CR73) 2013; 14 Gniadecki, Assaf, Bagot, Dummer, Duvic, Knobler, Ranki, Schwandt, Whittaker (CR35) 2007; 157 Chen, Fan, Wang, Ma, Bower, Shi, Ke, Luo (CR44) 2007; 85 Zhang, Liu, Schroeder, Chan, Song, Yu, Weinshenker, Ye (CR32) 2014; 39 Zhang, Hazarika, Ni, Weidner, Duvic (CR43) 2002; 8 Veeraraghavalu, Zhang, Miller, Hefendehl, Rajapaksha, Ulrich, Jucker, Holtzman, Tanzi, Vassar, Sisodia (CR49) 2013; 340 Ulrich, Burchett, Restivo, Schuler, Verghese, Mahan, Landreth, Castellano, Jiang, Cirrito, Holtzman (CR33) 2013; 8 Gupta, You, Li, Klistorner, Graham (CR74) 2013; 49 Gupta, Chitranshi, You, Gupta, Klistorner, Graham (CR78) 2014; 454 Cramer, Cirrito, Wesson, Lee, Karlo, Zinn, Casali, Restivo, Goebel, James (CR19) 2012; 335 Matsumoto, Wada, Yamashiro, Kaplan, Thiele (CR26) 1995; 55 Nguyen, Lee, Lee, Lee, Ahn (CR75) 2009; 34 Edsjo, Lavenius, Nilsson, Hoehner, Simonsson, Culp, Martinsson, Larsson, Pahlman (CR25) 2003; 83 Mariani, Malm, Lamb, Jay, Neilson, Casali, Medarametla, Landreth (CR55) 2017; 7 Mangialasche, Solomon, Winblad, Mecocci, Kivipelto (CR3) 2010; 9 Rosenblum (CR4) 2014; 35 Etchamendy, Enderlin, Marighetto, Pallet, Higueret, Jaffard (CR17) 2003; 145 McFarland, Spalding, Hubbard, Ma, Olsson, Burstein (CR36) 2013; 4 Boehm, Zhang, Zhi, McClurg, Berger, Wagoner, Mais, Suto, Davies, Heyman (CR34) 1995; 38 Liao, Fung, Huang, Fang, Zhong, Liu (CR40) 2013; 87 Wu, Hung, Chen, Ke, Lee, Wang, Chen (CR76) 2014; 9 Devi, Ohno (CR31) 2012; 37 Ding, Yang, Zhang, Gu (CR67) 2012; 418 Gupta, You, Li, Gupta, Golzan, Klistorner, van den Buuse, Graham (CR79) 2014; 1842 Strober (CR81) 2015; 111 Koronyo-Hamaoui, Koronyo, Ljubimov, Miller, Ko, Black, Schwartz, Farkas (CR7) 2011; 54 Chiang, Misner, Kempermann, Schikorski, Giguere, Sucov, Gage, Stevens, Evans (CR12) 1998; 21 Kuntz, Candela, Saint-Pol, Lamartiniere, Boucau, Sevin, Fenart, Gosselet (CR54) 2015; 48 Alvarez, Sandoval, Leal, Castro, Kosik (CR68) 2004; 17 Cazorla, Jouvenceau, Rose, Guilloux, Pilon, Dranovsky, Premont (CR77) 2010; 5 Chitranshi, Dheer, Gupta, Abbasi, Mirzaei, You, Chung, Graham, Gupta (CR72) 2017; 364 Lefebvre, Benomar, Staels (CR9) 2010; 21 Barsony, Prufer (CR10) 2002; 65 Rozpędek, Nowak, Pytel, Lewko, Diehl, Majsterek (CR61) 2016; 12 Lucarelli, Kaplan, Thiele (CR27) 1995; 270 Ma, Zhang, Liu, Yue, Zhao, Xu (CR45) 2016; 2016 Gupta, Chitranshi, Gupta, Golzan, Dheer, Wall, Georgevsky, King, Vickers, Chung, Graham (CR6) 2016; 623 Boehm-Cagan, Michaelson (CR58) 2014; 34 Nagahara, Merrill, Coppola, Tsukada, Schroeder, Shaked, Wang, Blesch, Kim, Conner, Rockenstein, Chao, Koo, Geschwind, Masliah, Chiba, Tuszynski (CR80) 2009; 15 Wietrzych, Meziane, Sutter, Ghyselinck, Chapman, Chambon, Krezel (CR13) 2005; 12 Goodman (CR15) 2006; 209 Ding, Qiao, Wang, Goodwin, Lee, Block, Allsbrook, McDonald, Fan (CR16) 2008; 28 Cummings, Zhong, Kinney, Heaney, Moll-Tudla, Joshi, Pontecorvo, Devous, Tang, Bena (CR53) 2016; 8 Oyadomari, Mori (CR41) 2003; 11 Peng, Wuu, Mufson, Fahnestock (CR30) 2005; 93 Tesseur, Lo, Roberfroid, Dietvorst, Van Broeck, Borgers, Gijsen, Moechars, Mercken, Kemp (CR48) 2013; 340 Ho, Yang, Lau, Hung, Wuwongse, Zhang, Wang, Baum, So, Chang (CR60) 2012; 28 Brazda, Krieger, Daniel, Jonas, Szekeres, Langowski, Toth, Nagy, Vamosi (CR50) 2014; 34 Mounier, Georgiev, Nam, Fitz, Castranio, Wolfe, Cronican, Schug, Lefterov, Koldamova (CR51) 2015; 35 Nam, Mounier, Fitz, Wolfe, Schug, Lefterov, Koldamova (CR59) 2016; 6 Cornejo, Hetz (CR38) 2013; 35 Dummer, Beyer, Hymes, Epping, Bernards, Steinhoff, Sterry, Kerl, Heath, Ahern, Hardwick, Garcia-Vargas, Baumann, Rizvi, Frankel, Whittaker, Assaf (CR70) 2012; 53 Mingaud, Mormede, Etchamendy, Mons, Niedergang, Wietrzych, Pallet, Jaffard, Krezel, Higueret, Marighetto (CR23) 2008; 28 LaClair, Manaye, Lee, Allard, Savonenko, Troncoso, Wong (CR21) 2013; 8 Bachmeier, Beaulieu-Abdelahad, Crawford, Mullan, Paris (CR56) 2013; 49 Lane, Bailey (CR22) 2005; 75 Riancho, Ruiz-Soto, Berciano, Berciano, Lafarga (CR37) 2015; 9 Tabas, Ron (CR65) 2011; 13 Wang, Hara, Van Baaren, Price, Beecham, Gallins, Whitehead, Wang, Lu, Slifer (CR11) 2012; 33 Heyman, Mangelsdorf, Dyck, Stein, Eichele, Evans, Thaller (CR20) 1992; 68 Fonseca, Ferreiro, Oliveira, Cardoso, Pereira (CR39) 2013; 1832 Price, Milne, Sharkey, Matsuoka (CR24) 2007; 115 Bomben, Holth, Reed, Cramer, Landreth, Noebels (CR57) 2014; 35 Gupta, Gupta, Chitranshi, Gangoda, Vander Wall, Abbasi, Golzan, Dheer, Shah, Avolio, Chung, Martins, Graham (CR5) 2016; 73 Mangelsdorf, Borgmeyer, Heyman, Zhou, Ong, Oro, Kakizuka, Evans (CR14) 1992; 6 Holmes, Boche, Wilkinson, Yadegarfar, Hopkins, Bayer, Jones, Bullock, Love, Neal, Zotova, Nicoll (CR2) 2008; 372 Gupta, Laws, Villemagne, Ames, Bush, Ellis, Lui, Masters, Rowe, Szoeke, Taddei, Martins (CR8) 2011; 76 Zode, Sharma, Lin, Searby, Bugge, Kim, Clark, Sheffield (CR62) 2014; 124 Szegezdi, Logue, Gorman, Samali (CR66) 2006; 7 Fitz, Cronican, Lefterov, Koldamova (CR46) 2013; 340 Kawahara, Suenobu, Ohtsuka, Kuniyasu, Sugimoto, Nakagomi, Fukasawa, Shudo, Nakayama (CR64) 2014; 42 Budgin, Richardson, Newton, Wysocka, Zaki, Benoit, Rook (CR42) 2005; 141 Goldsworthy, Vallence (CR1) 2013; 33 Cancino, Toledo, Leal, Hernandez, Yévenes, Inestrosa, Alvarez (CR69) 2008; 131 Huuskonen, Loppi, Dhungana, Keksa-Goldsteine, Lemarchant, Korhonen, Wojciechowski, Pollari, Valonen, Koponen, Takashima, Landreth, Goldsteins, Malm, Koistinaho, Kanninen (CR71) 2016; 6 Mandrekar-Colucci, Landreth (CR18) 2011; 15 Jeronimo-Santos, Vaz, Parreira, Rapaz-Lerias, Caetano, Buee-Scherrer, Castren, Valente, Blum, Sebastiao, Diogenes (CR29) 2015; 25 Tai, Koster, Luo, Lee, Wang, Collins, Ben Aissa, Thatcher, LaDu (CR52) 2014; 289 Paschen, Mengesdorf (CR63) 2005; 38 F Mingaud (1041_CR23) 2008; 28 E Szegezdi (1041_CR66) 2006; 7 CH Wu (1041_CR76) 2014; 9 I Tesseur (1041_CR48) 2013; 340 YS Ho (1041_CR60) 2012; 28 VB Gupta (1041_CR8) 2011; 76 RD Price (1041_CR24) 2007; 115 MA Lane (1041_CR22) 2005; 75 ACRG Fonseca (1041_CR39) 2013; 1832 VH Cornejo (1041_CR38) 2013; 35 W Paschen (1041_CR63) 2005; 38 VK Gupta (1041_CR73) 2013; 14 N Etchamendy (1041_CR17) 2003; 145 S Oyadomari (1041_CR41) 2003; 11 L Minichiello (1041_CR28) 2009; 10 M Cazorla (1041_CR77) 2010; 5 WI Rosenblum (1041_CR4) 2014; 35 P Brazda (1041_CR50) 2014; 34 Y Liao (1041_CR40) 2013; 87 JB Budgin (1041_CR42) 2005; 141 AR Price (1041_CR47) 2013; 340 K Veeraraghavalu (1041_CR49) 2013; 340 V Gupta (1041_CR78) 2014; 454 W Strober (1041_CR81) 2015; 111 A Boehm-Cagan (1041_CR58) 2014; 34 V Gupta (1041_CR5) 2016; 73 VK Gupta (1041_CR6) 2016; 623 V Bomben (1041_CR57) 2014; 35 Y Ding (1041_CR16) 2008; 28 A Jeronimo-Santos (1041_CR29) 2015; 25 MT Huuskonen (1041_CR71) 2016; 6 E Lucarelli (1041_CR27) 1995; 270 C Holmes (1041_CR2) 2008; 372 LM Tai (1041_CR52) 2014; 289 M Wietrzych (1041_CR13) 2005; 12 MM Mariani (1041_CR55) 2017; 7 I Tabas (1041_CR65) 2011; 13 S Mandrekar-Colucci (1041_CR18) 2011; 15 K Matsumoto (1041_CR26) 1995; 55 KN Nam (1041_CR59) 2016; 6 K Kawahara (1041_CR64) 2014; 42 GI Cancino (1041_CR69) 2008; 131 L Wang (1041_CR11) 2012; 33 J Riancho (1041_CR37) 2015; 9 W Rozpędek (1041_CR61) 2016; 12 MY Chiang (1041_CR12) 1998; 21 K McFarland (1041_CR36) 2013; 4 N Nguyen (1041_CR75) 2009; 34 F Mangialasche (1041_CR3) 2010; 9 L Devi (1041_CR31) 2012; 37 M Koronyo-Hamaoui (1041_CR7) 2011; 54 S Peng (1041_CR30) 2005; 93 P Lefebvre (1041_CR9) 2010; 21 R Gniadecki (1041_CR35) 2007; 157 GS Zode (1041_CR62) 2014; 124 JD Ulrich (1041_CR33) 2013; 8 Z Zhang (1041_CR32) 2014; 39 RA Heyman (1041_CR20) 1992; 68 VK Gupta (1041_CR74) 2013; 49 AR Alvarez (1041_CR68) 2004; 17 DJ Mangelsdorf (1041_CR14) 1992; 6 C Zhang (1041_CR43) 2002; 8 R Ma (1041_CR45) 2016; 2016 A Edsjo (1041_CR25) 2003; 83 AH Nagahara (1041_CR80) 2009; 15 AB Goodman (1041_CR15) 2006; 209 M Kuntz (1041_CR54) 2015; 48 J Barsony (1041_CR10) 2002; 65 PE Cramer (1041_CR19) 2012; 335 MR Goldsworthy (1041_CR1) 2013; 33 JL Cummings (1041_CR53) 2016; 8 C Bachmeier (1041_CR56) 2013; 49 MF Boehm (1041_CR34) 1995; 38 R Dummer (1041_CR70) 2012; 53 V Gupta (1041_CR79) 2014; 1842 NF Fitz (1041_CR46) 2013; 340 A Mounier (1041_CR51) 2015; 35 G Chen (1041_CR44) 2007; 85 N Chitranshi (1041_CR72) 2017; 364 W Ding (1041_CR67) 2012; 418 KD LaClair (1041_CR21) 2013; 8
References_xml	– volume: 9 start-page: 250 year: 2015 ident: CR37 article-title: Neuroprotective effect of Bexarotene in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis publication-title: Front Cell Neurosci doi: 10.3389/fncel.2015.00250 – volume: 9 start-page: 702 year: 2010 end-page: 716 ident: CR3 article-title: Alzheimer’s disease: Clinical trials and drug development publication-title: Lancet Neurol doi: 10.1016/S1474-4422(10)70119-8 – volume: 33 start-page: 12910 year: 2013 end-page: 12911 ident: CR1 article-title: The role of β-amyloid in Alzheimer's disease-related neurodegeneration publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2252-13.2013 – volume: 35 start-page: 11862 year: 2015 end-page: 11876 ident: CR51 article-title: Bexarotene-activated retinoid X receptors regulate neuronal differentiation and dendritic complexity publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1001-15.2015 – volume: 418 start-page: 451 year: 2012 end-page: 456 ident: CR67 article-title: Reactive oxygen species-mediated endoplasmic reticulum stress contributes to aldosterone-induced apoptosis in tubular epithelial cells publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2012.01.037 – volume: 25 start-page: 3107 year: 2015 end-page: 3121 ident: CR29 article-title: Dysregulation of TrkB receptors and BDNF function by amyloid-beta peptide is mediated by Calpain publication-title: Cereb Cortex doi: 10.1093/cercor/bhu105 – volume: 38 start-page: 3146 year: 1995 end-page: 3155 ident: CR34 article-title: Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells publication-title: J Med Chem doi: 10.1021/jm00016a018 – volume: 28 start-page: 839 year: 2012 end-page: 854 ident: CR60 article-title: Endoplasmic reticulum stress induces tau pathology and forms a vicious cycle: Implication in Alzheimer’s disease pathogenesis publication-title: J Alzheimers Dis doi: 10.3233/JAD-2011-111037 – volume: 145 start-page: 37 year: 2003 end-page: 49 ident: CR17 article-title: Vitamin a deficiency and relational memory deficit in adult mice: Relationships with changes in brain retinoid signalling publication-title: Behav Brain Res doi: 10.1016/S0166-4328(03)00099-8 – volume: 55 start-page: 1798 year: 1995 end-page: 1806 ident: CR26 article-title: Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells publication-title: Cancer Res – volume: 83 start-page: 813 year: 2003 end-page: 823 ident: CR25 article-title: Expression of trkB in human neuroblastoma in relation to MYCN expression and retinoic acid treatment publication-title: Lab Investig doi: 10.1097/01.LAB.0000074895.48776.D8 – volume: 289 start-page: 30538 year: 2014 end-page: 30555 ident: CR52 article-title: Amyloid-beta pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo publication-title: J Biol Chem doi: 10.1074/jbc.M114.600833 – volume: 8 start-page: 13 year: 2013 ident: CR33 article-title: In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis publication-title: Mol Neurodegener doi: 10.1186/1750-1326-8-13 – volume: 35 start-page: 2091 year: 2014 end-page: 2095 ident: CR57 article-title: Bexarotene reduces network excitability in models of Alzheimer's disease and epilepsy publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2014.03.029 – volume: 7 start-page: 880 year: 2006 end-page: 885 ident: CR66 article-title: Mediators of endoplasmic reticulum stress-induced apoptosis publication-title: EMBO Rep doi: 10.1038/sj.embor.7400779 – volume: 157 start-page: 433 year: 2007 end-page: 440 ident: CR35 article-title: The optimal use of bexarotene in cutaneous T-cell lymphoma publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2007.07975.x – volume: 37 start-page: 434 year: 2012 end-page: 444 ident: CR31 article-title: 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease publication-title: Neuropsychopharmacology doi: 10.1038/npp.2011.191 – volume: 53 start-page: 1501 year: 2012 end-page: 1508 ident: CR70 article-title: Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: In vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition publication-title: Leuk Lymphoma doi: 10.3109/10428194.2012.656625 – volume: 12 start-page: 48 year: 2016 ident: CR61 article-title: The role of the Amyloid Precursor Protein mutations and PERK-dependent signaling pathways in the pathogenesis of Alzheimer’s disease publication-title: Folia Biol Oecol doi: 10.1515/fobio-2016-0005 – volume: 10 start-page: 850 year: 2009 end-page: 860 ident: CR28 article-title: TrkB signalling pathways in LTP and learning publication-title: Nat Rev Neurosci doi: 10.1038/nrn2738 – volume: 48 start-page: 849 year: 2015 end-page: 862 ident: CR54 article-title: Bexarotene promotes cholesterol efflux and restricts apical-to-basolateral transport of amyloid-beta peptides in an in vitro model of the human blood-brain barrier publication-title: J Alzheimers Dis doi: 10.3233/JAD-150469 – volume: 65 start-page: 345 year: 2002 end-page: 376 ident: CR10 article-title: Vitamin D receptor and retinoid X receptor interactions in motion publication-title: Vitam Horm doi: 10.1016/S0083-6729(02)65071-X – volume: 8 start-page: 18 year: 2013 ident: CR21 article-title: Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice publication-title: Mol Neurodegener doi: 10.1186/1750-1326-8-18 – volume: 209 start-page: 598 year: 2006 end-page: 603 ident: CR15 article-title: Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease publication-title: J Cell Physiol doi: 10.1002/jcp.20784 – volume: 49 start-page: 96 year: 2013 end-page: 104 ident: CR74 article-title: Protective effects of 7,8-Dihydroxyflavone on retinal ganglion and RGC-5 cells against Excitotoxic and oxidative stress publication-title: J Mol Neurosci doi: 10.1007/s12031-012-9899-x – volume: 21 start-page: 676 year: 2010 end-page: 683 ident: CR9 article-title: Retinoid X receptors: Common heterodimerization partners with distinct functions publication-title: Trends Endocrinol Metab doi: 10.1016/j.tem.2010.06.009 – volume: 15 start-page: 331 year: 2009 end-page: 337 ident: CR80 article-title: Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease publication-title: Nat Med doi: 10.1038/nm.1912 – volume: 93 start-page: 1412 year: 2005 end-page: 1421 ident: CR30 article-title: Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease publication-title: J Neurochem doi: 10.1111/j.1471-4159.2005.03135.x – volume: 87 start-page: 8124 year: 2013 end-page: 8134 ident: CR40 article-title: Upregulation of CHOP/GADD153 during coronavirus infectious bronchitis virus infection modulates apoptosis by restricting activation of the extracellular signal-regulated kinase pathway publication-title: J Virol doi: 10.1128/JVI.00626-13 – volume: 34 start-page: 942 year: 2009 end-page: 951 ident: CR75 article-title: Neuroprotection by NGF and BDNF against neurotoxin-exerted apoptotic death in neural stem cells are mediated through Trk receptors, activating PI3-kinase and MAPK pathways publication-title: Neurochem Res doi: 10.1007/s11064-008-9848-9 – volume: 270 start-page: 24725 year: 1995 end-page: 24731 ident: CR27 article-title: Selective regulation of TrkA and TrkB receptors by retinoic acid and interferon-gamma in human neuroblastoma cell lines publication-title: J Biol Chem doi: 10.1074/jbc.270.42.24725 – volume: 39 start-page: 638 year: 2014 end-page: 650 ident: CR32 article-title: 7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer's disease publication-title: Neuropsychopharmacology doi: 10.1038/npp.2013.243 – volume: 340 start-page: 924-e year: 2013 ident: CR48 article-title: Comment on “ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models” publication-title: Science doi: 10.1126/science.1233937 – volume: 141 start-page: 315 year: 2005 end-page: 321 ident: CR42 article-title: Biological effects of bexarotene in cutaneous T-cell lymphoma publication-title: Arch Dermatol doi: 10.1001/archderm.141.3.315 – volume: 335 start-page: 1503 year: 2012 end-page: 1506 ident: CR19 article-title: ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models publication-title: Science doi: 10.1126/science.1217697 – volume: 364 start-page: 175 year: 2017 end-page: 189 ident: CR72 article-title: PTPN11 induces endoplasmic stress and apoptosis in SH-SY5Y cells publication-title: Neuroscience doi: 10.1016/j.neuroscience.2017.09.028 – volume: 34 start-page: 7293 year: 2014 end-page: 7301 ident: CR58 article-title: Reversal of apoE4-driven brain pathology and behavioral deficits by Bexarotene publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5198-13.2014 – volume: 4 start-page: 1430 year: 2013 end-page: 1438 ident: CR36 article-title: Low dose bexarotene treatment rescues dopamine neurons and restores behavioral function in models of Parkinson's disease publication-title: ACS Chem Neurosci doi: 10.1021/cn400100f – volume: 6 start-page: 24048 year: 2016 ident: CR59 article-title: RXR controlled regulatory networks identified in mouse brain counteract deleterious effects of Aβ oligomers publication-title: Sci Rep doi: 10.1038/srep24048 – volume: 6 start-page: 33176 year: 2016 ident: CR71 article-title: Bexarotene targets autophagy and is protective against thromboembolic stroke in aged mice with tauopathy publication-title: Sci Rep doi: 10.1038/srep33176 – volume: 6 start-page: 329 year: 1992 end-page: 344 ident: CR14 article-title: Characterization of three RXR genes that mediate the action of 9-cis retinoic acid publication-title: Genes Dev doi: 10.1101/gad.6.3.329 – volume: 340 start-page: 924-d year: 2013 ident: CR47 article-title: Comment on “ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models” publication-title: Science doi: 10.1126/science.1234089 – volume: 5 start-page: e9777 year: 2010 ident: CR77 article-title: Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice publication-title: PLoS One doi: 10.1371/journal.pone.0009777 – volume: 15 start-page: 1085 year: 2011 end-page: 1097 ident: CR18 article-title: Nuclear receptors as therapeutic targets for Alzheimer's disease publication-title: Expert Opin Ther Targets doi: 10.1517/14728222.2011.594043 – volume: 131 start-page: 2425 year: 2008 end-page: 2442 ident: CR69 article-title: STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's β-amyloid deposits publication-title: Brain doi: 10.1093/brain/awn125 – volume: 28 start-page: 279 year: 2008 end-page: 291 ident: CR23 article-title: Retinoid hyposignaling contributes to aging-related decline in hippocampal function in short-term/working memory organization and long-term declarative memory encoding in mice publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4065-07.2008 – volume: 42 start-page: 587 year: 2014 end-page: 605 ident: CR64 article-title: Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease publication-title: J Alzheimers Dis doi: 10.3233/JAD-132720 – volume: 14 start-page: 10122 year: 2013 end-page: 10142 ident: CR73 article-title: TrkB receptor Signalling: Implications in neurodegenerative, psychiatric and proliferative disorders publication-title: Int J Mol Sci doi: 10.3390/ijms140510122 – volume: 2016 start-page: 5029797 year: 2016 ident: CR45 article-title: 7,8-DHF treatment induces Cyr61 expression to suppress hypoxia induced ER stress in HK-2 cells publication-title: Biomed Res Int – volume: 11 start-page: 381 year: 2003 end-page: 389 ident: CR41 article-title: Roles of CHOP//GADD153 in endoplasmic reticulum stress publication-title: Cell Death Differ doi: 10.1038/sj.cdd.4401373 – volume: 111 start-page: A3 B 1 year: 2015 end-page: A3 B 3 ident: CR81 article-title: Trypan blue exclusion test of cell viability publication-title: Curr Protoc Immunol doi: 10.1002/0471142735.ima03bs111 – volume: 8 start-page: 4 year: 2016 ident: CR53 article-title: Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease publication-title: Alzheimers Res Ther doi: 10.1186/s13195-016-0173-2 – volume: 454 start-page: 381 year: 2014 end-page: 386 ident: CR78 article-title: Brain derived neurotrophic factor is involved in the regulation of glycogen synthase kinase 3beta (GSK3beta) signalling publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2014.10.087 – volume: 372 start-page: 216 year: 2008 end-page: 223 ident: CR2 article-title: Long-term effects of Abeta42 immunisation in Alzheimer's disease: Follow-up of a randomised, placebo-controlled phase I trial publication-title: Lancet doi: 10.1016/S0140-6736(08)61075-2 – volume: 76 start-page: 1091 year: 2011 end-page: 1098 ident: CR8 article-title: Plasma apolipoprotein E and Alzheimer disease risk: The AIBL study of aging publication-title: Neurology doi: 10.1212/WNL.0b013e318211c352 – volume: 73 start-page: 4279 year: 2016 end-page: 4297 ident: CR5 article-title: One protein, multiple pathologies: Multifaceted involvement of amyloid beta in neurodegenerative disorders of the brain and retina publication-title: Cell Mol Life Sci doi: 10.1007/s00018-016-2295-x – volume: 340 start-page: 924-c year: 2013 ident: CR46 article-title: Comment on “ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models” publication-title: Science doi: 10.1126/science.1235809 – volume: 340 start-page: 924-f year: 2013 ident: CR49 article-title: Comment on “ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models” publication-title: Science doi: 10.1126/science.1235505 – volume: 13 start-page: 184 year: 2011 end-page: 190 ident: CR65 article-title: Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress publication-title: Nat Cell Biol doi: 10.1038/ncb0311-184 – volume: 1842 start-page: 1567 year: 2014 end-page: 1578 ident: CR79 article-title: BDNF impairment is associated with age-related changes in the inner retina and exacerbates experimental glaucoma publication-title: Biochim Biophys Acta doi: 10.1016/j.bbadis.2014.05.026 – volume: 38 start-page: 409 year: 2005 end-page: 415 ident: CR63 article-title: Endoplasmic reticulum stress response and neurodegeneration publication-title: Cell Calcium doi: 10.1016/j.ceca.2005.06.019 – volume: 68 start-page: 397 year: 1992 end-page: 406 ident: CR20 article-title: 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor publication-title: Cell doi: 10.1016/0092-8674(92)90479-V – volume: 623 start-page: 52 year: 2016 end-page: 56 ident: CR6 article-title: Amyloid beta accumulation and inner retinal degenerative changes in Alzheimer's disease transgenic mouse publication-title: Neurosci Lett doi: 10.1016/j.neulet.2016.04.059 – volume: 17 start-page: 326 year: 2004 end-page: 336 ident: CR68 article-title: Activation of the neuronal c-Abl tyrosine kinase by amyloid-β-peptide and reactive oxygen species publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2004.06.007 – volume: 8 start-page: 1234 year: 2002 end-page: 1240 ident: CR43 article-title: Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: Relevance to mechanism of therapeutic action publication-title: Clin Cancer Res – volume: 33 start-page: 1844 year: 2012 ident: CR11 article-title: Vitamin D receptor and Alzheimer's disease: A genetic and functional study publication-title: Neurobiol Aging – volume: 28 start-page: 11622 year: 2008 end-page: 11634 ident: CR16 article-title: Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model publication-title: J Neurosci doi: 10.1523/JNEUROSCI.3153-08.2008 – volume: 115 start-page: 292 year: 2007 end-page: 306 ident: CR24 article-title: Advances in small molecules promoting neurotrophic function publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2007.03.005 – volume: 12 start-page: 318 year: 2005 end-page: 326 ident: CR13 article-title: Working memory deficits in retinoid X receptor gamma-deficient mice publication-title: Learn Mem doi: 10.1101/lm.89805 – volume: 34 start-page: 1234 year: 2014 end-page: 1245 ident: CR50 article-title: Ligand binding shifts highly mobile retinoid X receptor to the chromatin-bound state in a coactivator-dependent manner, as revealed by single-cell imaging publication-title: Mol Cell Biol doi: 10.1128/MCB.01097-13 – volume: 7 start-page: 42270 year: 2017 ident: CR55 article-title: Neuronally-directed effects of RXR activation in a mouse model of Alzheimer’s disease publication-title: Sci Rep doi: 10.1038/srep42270 – volume: 9 start-page: e113397 year: 2014 ident: CR76 article-title: Post-injury treatment with 7,8-dihydroxyflavone, a TrkB receptor agonist, protects against experimental traumatic brain injury via PI3K/Akt signaling publication-title: PLoS One doi: 10.1371/journal.pone.0113397 – volume: 54 start-page: S204 issue: Suppl 1 year: 2011 end-page: S217 ident: CR7 article-title: Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model publication-title: NeuroImage doi: 10.1016/j.neuroimage.2010.06.020 – volume: 35 start-page: 277 year: 2013 end-page: 292 ident: CR38 article-title: The unfolded protein response in Alzheimer's disease publication-title: Semin Immunopathol doi: 10.1007/s00281-013-0373-9 – volume: 75 start-page: 275 year: 2005 end-page: 293 ident: CR22 article-title: Role of retinoid signalling in the adult brain publication-title: Prog Neurobiol doi: 10.1016/j.pneurobio.2005.03.002 – volume: 1832 start-page: 2191 year: 2013 end-page: 2203 ident: CR39 article-title: Activation of the endoplasmic reticulum stress response by the amyloid-beta 1-40 peptide in brain endothelial cells publication-title: Biochim Biophys Acta (BBA) - Mol Basis Dis doi: 10.1016/j.bbadis.2013.08.007 – volume: 124 start-page: 1956 year: 2014 end-page: 1965 ident: CR62 article-title: Ocular-specific ER stress reduction rescues glaucoma in murine glucocorticoid-induced glaucoma publication-title: J Clin Invest doi: 10.1172/JCI69774 – volume: 21 start-page: 1353 year: 1998 end-page: 1361 ident: CR12 article-title: An essential role for retinoid receptors RARbeta and RXRgamma in long-term potentiation and depression publication-title: Neuron doi: 10.1016/S0896-6273(00)80654-6 – volume: 85 start-page: 1674 year: 2007 end-page: 1684 ident: CR44 article-title: Brain-derived neurotrophic factor suppresses tunicamycin-induced upregulation of CHOP in neurons publication-title: J Neurosci Res doi: 10.1002/jnr.21292 – volume: 49 start-page: 270 year: 2013 end-page: 276 ident: CR56 article-title: Stimulation of the retinoid X receptor facilitates Beta-amyloid clearance across the blood–brain barrier publication-title: J Mol Neurosci doi: 10.1007/s12031-012-9866-6 – volume: 35 start-page: 969 year: 2014 end-page: 974 ident: CR4 article-title: Why Alzheimer trials fail: Removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2013.10.085 – volume: 15 start-page: 1085 year: 2011 ident: 1041_CR18 publication-title: Expert Opin Ther Targets doi: 10.1517/14728222.2011.594043 – volume: 8 start-page: 18 year: 2013 ident: 1041_CR21 publication-title: Mol Neurodegener doi: 10.1186/1750-1326-8-18 – volume: 340 start-page: 924-f year: 2013 ident: 1041_CR49 publication-title: Science doi: 10.1126/science.1235505 – volume: 340 start-page: 924-d year: 2013 ident: 1041_CR47 publication-title: Science doi: 10.1126/science.1234089 – volume: 8 start-page: 1234 year: 2002 ident: 1041_CR43 publication-title: Clin Cancer Res – volume: 34 start-page: 942 year: 2009 ident: 1041_CR75 publication-title: Neurochem Res doi: 10.1007/s11064-008-9848-9 – volume: 55 start-page: 1798 year: 1995 ident: 1041_CR26 publication-title: Cancer Res – volume: 11 start-page: 381 year: 2003 ident: 1041_CR41 publication-title: Cell Death Differ doi: 10.1038/sj.cdd.4401373 – volume: 28 start-page: 839 year: 2012 ident: 1041_CR60 publication-title: J Alzheimers Dis doi: 10.3233/JAD-2011-111037 – volume: 35 start-page: 2091 year: 2014 ident: 1041_CR57 publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2014.03.029 – volume: 418 start-page: 451 year: 2012 ident: 1041_CR67 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2012.01.037 – volume: 4 start-page: 1430 year: 2013 ident: 1041_CR36 publication-title: ACS Chem Neurosci doi: 10.1021/cn400100f – volume: 289 start-page: 30538 year: 2014 ident: 1041_CR52 publication-title: J Biol Chem doi: 10.1074/jbc.M114.600833 – volume: 209 start-page: 598 year: 2006 ident: 1041_CR15 publication-title: J Cell Physiol doi: 10.1002/jcp.20784 – volume: 28 start-page: 11622 year: 2008 ident: 1041_CR16 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.3153-08.2008 – volume: 87 start-page: 8124 year: 2013 ident: 1041_CR40 publication-title: J Virol doi: 10.1128/JVI.00626-13 – volume: 6 start-page: 329 year: 1992 ident: 1041_CR14 publication-title: Genes Dev doi: 10.1101/gad.6.3.329 – volume: 6 start-page: 24048 year: 2016 ident: 1041_CR59 publication-title: Sci Rep doi: 10.1038/srep24048 – volume: 124 start-page: 1956 year: 2014 ident: 1041_CR62 publication-title: J Clin Invest doi: 10.1172/JCI69774 – volume: 157 start-page: 433 year: 2007 ident: 1041_CR35 publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2007.07975.x – volume: 75 start-page: 275 year: 2005 ident: 1041_CR22 publication-title: Prog Neurobiol doi: 10.1016/j.pneurobio.2005.03.002 – volume: 8 start-page: 13 year: 2013 ident: 1041_CR33 publication-title: Mol Neurodegener doi: 10.1186/1750-1326-8-13 – volume: 65 start-page: 345 year: 2002 ident: 1041_CR10 publication-title: Vitam Horm doi: 10.1016/S0083-6729(02)65071-X – volume: 68 start-page: 397 year: 1992 ident: 1041_CR20 publication-title: Cell doi: 10.1016/0092-8674(92)90479-V – volume: 85 start-page: 1674 year: 2007 ident: 1041_CR44 publication-title: J Neurosci Res doi: 10.1002/jnr.21292 – volume: 270 start-page: 24725 year: 1995 ident: 1041_CR27 publication-title: J Biol Chem doi: 10.1074/jbc.270.42.24725 – volume: 454 start-page: 381 year: 2014 ident: 1041_CR78 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2014.10.087 – volume: 73 start-page: 4279 year: 2016 ident: 1041_CR5 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-016-2295-x – volume: 42 start-page: 587 year: 2014 ident: 1041_CR64 publication-title: J Alzheimers Dis doi: 10.3233/JAD-132720 – volume: 49 start-page: 270 year: 2013 ident: 1041_CR56 publication-title: J Mol Neurosci doi: 10.1007/s12031-012-9866-6 – volume: 9 start-page: 250 year: 2015 ident: 1041_CR37 publication-title: Front Cell Neurosci doi: 10.3389/fncel.2015.00250 – volume: 372 start-page: 216 year: 2008 ident: 1041_CR2 publication-title: Lancet doi: 10.1016/S0140-6736(08)61075-2 – volume: 21 start-page: 1353 year: 1998 ident: 1041_CR12 publication-title: Neuron doi: 10.1016/S0896-6273(00)80654-6 – volume: 111 start-page: A3 B 1 year: 2015 ident: 1041_CR81 publication-title: Curr Protoc Immunol doi: 10.1002/0471142735.ima03bs111 – volume: 115 start-page: 292 year: 2007 ident: 1041_CR24 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2007.03.005 – volume: 7 start-page: 880 year: 2006 ident: 1041_CR66 publication-title: EMBO Rep doi: 10.1038/sj.embor.7400779 – volume: 14 start-page: 10122 year: 2013 ident: 1041_CR73 publication-title: Int J Mol Sci doi: 10.3390/ijms140510122 – volume: 131 start-page: 2425 year: 2008 ident: 1041_CR69 publication-title: Brain doi: 10.1093/brain/awn125 – volume: 145 start-page: 37 year: 2003 ident: 1041_CR17 publication-title: Behav Brain Res doi: 10.1016/S0166-4328(03)00099-8 – volume: 6 start-page: 33176 year: 2016 ident: 1041_CR71 publication-title: Sci Rep doi: 10.1038/srep33176 – volume: 9 start-page: e113397 year: 2014 ident: 1041_CR76 publication-title: PLoS One doi: 10.1371/journal.pone.0113397 – volume: 12 start-page: 318 year: 2005 ident: 1041_CR13 publication-title: Learn Mem doi: 10.1101/lm.89805 – volume: 340 start-page: 924-e year: 2013 ident: 1041_CR48 publication-title: Science doi: 10.1126/science.1233937 – volume: 17 start-page: 326 year: 2004 ident: 1041_CR68 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2004.06.007 – volume: 35 start-page: 969 year: 2014 ident: 1041_CR4 publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2013.10.085 – volume: 364 start-page: 175 year: 2017 ident: 1041_CR72 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2017.09.028 – volume: 53 start-page: 1501 year: 2012 ident: 1041_CR70 publication-title: Leuk Lymphoma doi: 10.3109/10428194.2012.656625 – volume: 9 start-page: 702 year: 2010 ident: 1041_CR3 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(10)70119-8 – volume: 35 start-page: 11862 year: 2015 ident: 1041_CR51 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1001-15.2015 – volume: 13 start-page: 184 year: 2011 ident: 1041_CR65 publication-title: Nat Cell Biol doi: 10.1038/ncb0311-184 – volume: 335 start-page: 1503 year: 2012 ident: 1041_CR19 publication-title: Science doi: 10.1126/science.1217697 – volume: 25 start-page: 3107 year: 2015 ident: 1041_CR29 publication-title: Cereb Cortex doi: 10.1093/cercor/bhu105 – volume: 49 start-page: 96 year: 2013 ident: 1041_CR74 publication-title: J Mol Neurosci doi: 10.1007/s12031-012-9899-x – volume: 33 start-page: 12910 year: 2013 ident: 1041_CR1 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2252-13.2013 – volume: 35 start-page: 277 year: 2013 ident: 1041_CR38 publication-title: Semin Immunopathol doi: 10.1007/s00281-013-0373-9 – volume: 7 start-page: 42270 year: 2017 ident: 1041_CR55 publication-title: Sci Rep doi: 10.1038/srep42270 – volume: 39 start-page: 638 year: 2014 ident: 1041_CR32 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2013.243 – volume: 28 start-page: 279 year: 2008 ident: 1041_CR23 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4065-07.2008 – volume: 5 start-page: e9777 year: 2010 ident: 1041_CR77 publication-title: PLoS One doi: 10.1371/journal.pone.0009777 – volume: 8 start-page: 4 year: 2016 ident: 1041_CR53 publication-title: Alzheimers Res Ther doi: 10.1186/s13195-016-0173-2 – volume: 38 start-page: 409 year: 2005 ident: 1041_CR63 publication-title: Cell Calcium doi: 10.1016/j.ceca.2005.06.019 – volume: 340 start-page: 924-c year: 2013 ident: 1041_CR46 publication-title: Science doi: 10.1126/science.1235809 – volume: 34 start-page: 1234 year: 2014 ident: 1041_CR50 publication-title: Mol Cell Biol doi: 10.1128/MCB.01097-13 – volume: 48 start-page: 849 year: 2015 ident: 1041_CR54 publication-title: J Alzheimers Dis doi: 10.3233/JAD-150469 – volume: 10 start-page: 850 year: 2009 ident: 1041_CR28 publication-title: Nat Rev Neurosci doi: 10.1038/nrn2738 – volume: 76 start-page: 1091 year: 2011 ident: 1041_CR8 publication-title: Neurology doi: 10.1212/WNL.0b013e318211c352 – volume: 141 start-page: 315 year: 2005 ident: 1041_CR42 publication-title: Arch Dermatol doi: 10.1001/archderm.141.3.315 – volume: 1842 start-page: 1567 year: 2014 ident: 1041_CR79 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbadis.2014.05.026 – volume: 37 start-page: 434 year: 2012 ident: 1041_CR31 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2011.191 – volume: 1832 start-page: 2191 year: 2013 ident: 1041_CR39 publication-title: Biochim Biophys Acta (BBA) - Mol Basis Dis doi: 10.1016/j.bbadis.2013.08.007 – volume: 623 start-page: 52 year: 2016 ident: 1041_CR6 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2016.04.059 – volume: 83 start-page: 813 year: 2003 ident: 1041_CR25 publication-title: Lab Investig doi: 10.1097/01.LAB.0000074895.48776.D8 – volume: 93 start-page: 1412 year: 2005 ident: 1041_CR30 publication-title: J Neurochem doi: 10.1111/j.1471-4159.2005.03135.x – volume: 15 start-page: 331 year: 2009 ident: 1041_CR80 publication-title: Nat Med doi: 10.1038/nm.1912 – volume: 54 start-page: S204 issue: Suppl 1 year: 2011 ident: 1041_CR7 publication-title: NeuroImage doi: 10.1016/j.neuroimage.2010.06.020 – volume: 38 start-page: 3146 year: 1995 ident: 1041_CR34 publication-title: J Med Chem doi: 10.1021/jm00016a018 – volume: 21 start-page: 676 year: 2010 ident: 1041_CR9 publication-title: Trends Endocrinol Metab doi: 10.1016/j.tem.2010.06.009 – volume: 34 start-page: 7293 year: 2014 ident: 1041_CR58 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5198-13.2014 – volume: 33 start-page: 1844 year: 2012 ident: 1041_CR11 publication-title: Neurobiol Aging – volume: 2016 start-page: 5029797 year: 2016 ident: 1041_CR45 publication-title: Biomed Res Int – volume: 12 start-page: 48 year: 2016 ident: 1041_CR61 publication-title: Folia Biol Oecol doi: 10.1515/fobio-2016-0005
SSID	ssj0022107
Score	2.4214916
Snippet	Retinoid X-receptors (RXRs) are members of the ligand-dependent transcription factor family of nuclear receptors that have gained recent research focus as...
SourceID	proquest pubmed crossref springer
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	9043
SubjectTerms	Alzheimer Disease - drug therapy Alzheimer Disease - metabolism Alzheimer Disease - pathology Amyloid beta-Peptides - metabolism Animals Apoptosis Apoptosis - drug effects Bad protein bcl-Associated Death Protein - metabolism Bexarotene - pharmacology Bexarotene - therapeutic use Biomedical and Life Sciences Biomedicine Cell Biology Cell Line, Tumor Cell Survival - drug effects Disease Models, Animal Endoplasmic reticulum Endoplasmic Reticulum Stress - drug effects Glial cells Heat shock proteins Humans Immunofluorescence Isoforms Male Mice, Inbred C57BL Neurobiology Neuroblasts Neurodegenerative diseases Neurology Neuroprotection Neuroprotection - drug effects Neurosciences Neurotoxicity Neurotoxicity Syndromes - drug therapy Neurotoxicity Syndromes - metabolism Neurotoxicity Syndromes - pathology Nuclear receptors Receptor, trkB - metabolism Retinoid X receptors Retinoid X Receptors - metabolism Signal transduction Stress response Therapeutic applications Therapeutic targets TrkB receptors Up-Regulation - drug effects Western blotting
SummonAdditionalLinks	– databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZtmmsfSR8uSVCg9JAiWMlaWzq6ZUMLbViSNuzNWNK4LCTyEm_aza_pX-1ItncJSQvtzdiyJNCM5hvN6BtC3igB2jhlmbUyY1KMNDM1z5hxNRojXRsV6YvPP-cnJ2o209P-Hnc7ZLsPIcm4U28uu4lArzjigY5UcqYfkkdo7VTQxtOz87WXhT5MR--pU5ZnUg2hzPu6uG2M7iDMO9HRaHSOn_zXdJ-Sxz3GpEUnFM_IA_A7ZLfw6F9f3tC3NGZ9xuP0XfLrPayqwNXggX5pXCjmBS09DRehm7ljM4a4EhbomNPJqs-Z9bTyjn5q6bTjeMD9khbfqzkCTRq5PpbNam7pxLtmgdj8Ep9Df_GckZ7Fuyn4IqbmQuyqWDQ4AragU8SjP6sbWtih6tpz8u148vXDR9YXbWBWpmrJ8nElc6OcNjC2emQ1N0LUxoFFW8nz2kGghJcCuHCGV07z1CHMMwoQCaE7nr4gW77x8IpQha4qiExI0CBdDSGnMMssuoCVRtzDEzIaVq-0PaN5KKxxUW64mMMilLgIZViEUifkaP3LoqPz-FvjvUEkyl6z2zKUmx-rDP36hByuP6NOhkBL5aG5jm1k3PnShLzsRGk9msAdL5AyJuTdIDebzv84ldf_1HqPbC2vrmGfbNsfy3l7dRA15DeJfA6- priority: 102 providerName: Springer Nature
Title	Bexarotene Modulates Retinoid-X-Receptor Expression and Is Protective Against Neurotoxic Endoplasmic Reticulum Stress Response and Apoptotic Pathway Activation
URI	https://link.springer.com/article/10.1007/s12035-018-1041-9 https://www.ncbi.nlm.nih.gov/pubmed/29637440 https://www.proquest.com/docview/2023586837 https://www.proquest.com/docview/2024017933
Volume	55
WOSCitedRecordID	wos000448483400020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1559-1182 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022107 issn: 0893-7648 databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFD5iGw-8cBuXwKiMhHgAWWocN7GfUIY6gUSrqIOpb1F8yVSJJWHpoPs1_FWOnaQVmtgLL1abuo6lYx9_n338HYA3glmpjNBUax5TzsaSqjKMqTIlLkayVMLLF599SeZzsVzKrN9wa_uwysEnekdtau32yB1JjyYiRj71oflBXdYod7rap9DYgwOnkhD50L1sS7iQznRKnzKiSczFcKrpr84xJ9Y4Dp24KQ-p_HtdugE2bxyU-vXn5MH_9vwh3O-RJ0m7ofII7tjqMRymFbLui2vylvhYUL_Jfgi_j-2mcAoOlSWz2rgUX7YlC3c9ul4ZuqSINm2DdJ1MN30kbUWKypDPLck65Qf0oiQ9L1YIP4lXAFnXm5Um08rUDSL2C_zs2vO7j-TU31jBBz5g1_qm0qbGN2ANkiFK_VVck1QPudiewLeT6dePn2ifyoFqHok1TSYFT5QwUtmJlmMtQ8VYqYzVuIKGSWmsE4rnzIbMqLAwMowMgj8lLOIjJOnRU9iv6so-ByKQwFoWM26l5aa0LtIwjjUSw0IiGgoDGA-GzHWvc-7SbXzPdwrNzvY52j53ts9lAO-2f2k6kY_bKh8NZs77-d7mOxsH8Hr7M85Ud_xSVLa-8nW494dRAM-6UbV9G0M_6KQaA3g_DLNd4__syovbu_IS7jE_wF3wzRHsry-v7Cu4q3-uV-3lCPaSZeJLMYKD4-k8W-C3GZv5Mhv5qYTl4vTsDxP5Iec
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9NAEB2VggQXvsqHocAiAQeqleL1xvYeEDKQqlGTKIKCcjP27rqK1Nomdmnya_gH_EZm13YiVNFbD9wiZ7227Lcz8zyzbwBehUyLVIWSSsl9yllP0DRzfZqqDJ2RyNLQyhd_GwWTSTibiekW_O72wpiyys4mWkOtCmm-kRuS7vVDH_nU-_IHNV2jTHa1a6HRwOJQr86RslXvhp_w_b5mbH9w9PGAtl0FqOReWNOgn_AgDZVIdV-KnhRuyliWKi3RmLtBprTRLOdMu0ylbqKE6ymMQ9JQo6tGvujhvNfgOkcmZFpFjNl4TfCQPjXKosKjgc_DLotqt-oxIw7Zc42YKnep-NsPXghuLyRmrb_bv_O_Pam7cLuNrEnULIV7sKXz-7AT5UldnK7IG2JrXW0SYQd-fdDLxChU5JqMC2VamOmKfDbbv4u5ojOK0bQu62JBBsu2UjgnSa7IsCLTRtkCvQSJjpM5htfEKpzUxXIuySBXRYmM5BR_m_ns11Xyxe7IwQO2IFnbqaKywCvgCDLFKPw8WZFIdr3mHsDXK3lUD2E7L3L9GEiIBF0zn3EtNFeZNpWUvi-R-CYCoz3XgV4HnFi2Ou6mnchJvFGgNliLEWuxwVosHHi7PqVsREwuG7zbwSpu7VkVbzDlwMv132iJTHopyXVxZsdwa-89Bx41KF5fjaGdN1KUDux1sN5M_s9beXL5rbyAmwdH41E8Gk4On8ItZheXKTTahe16caafwQ35s55Xi-d2mRL4ftVo_wPoqnhc
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VglAvvMrDUGCRgANoRbx2bO8BIUMTEbVEFi_lZuzddRWJek3s0uTX8D_4dcyu7USoorceuEXOem3Z387M55n9BuBpxBTPZSSoEH5AfTbgNC_cgOayQGfEizyy8sVfD8PpNJrNeLIFv_u9MKassreJ1lBLLcw3ckPSvWEUIJ96VXRlEcn--E31g5oOUibT2rfTaCFyoFanSN_q15N9fNfPGBuPPr97T7sOA1T4XtTQcJj5YR5Jnquh4APB3ZyxIpdKoGF3w0Iqo1_uM-UymbuZ5K4nMSbJI4VuG7mjh_NegsuhES23ZYPJmuwhlWpVRrlHw8CP-oyq3bbHjFDkwDXCqr5L-d8-8UygeyZJa33f-Pr__NRuwLUu4iZxu0RuwpYqb8FuXGaNPl6R58TWwNrkwi78equWmVGuKBX5oKVpbaZq8tFsC9dzSWcUo2xVNXpBRsuugrgkWSnJpCZJq3iB3oPER9kcw25ilU8avZwLMiqlrpCpHONvM5_96ko-2Z06eMAWKis7VVxpvAKOIAlG56fZisSi70F3G75cyKO6A9ulLtU9IBESd8UC5iuufFkoU2EZBAIJccYxCnQdGPQgSkWn727ajHxPN8rUBncp4i41uEu5Ay_Wp1StuMl5g_d6iKWdnavTDb4ceLL-Gy2USTtlpdIndoxv_YDnwN0W0eurMbT_RqLSgZc9xDeT__NW7p9_K4_hKoI8PZxMDx7ADrPrzNQf7cF2szhRD-GK-NnM68Uju2IJfLtosP8BBZuBLQ
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bexarotene+Modulates+Retinoid-X-Receptor+Expression+and+Is+Protective+Against+Neurotoxic+Endoplasmic+Reticulum+Stress+Response+and+Apoptotic+Pathway+Activation&rft.jtitle=Molecular+neurobiology&rft.au=Dheer%2C+Yogita&rft.au=Chitranshi%2C+Nitin&rft.au=Gupta%2C+Veer&rft.au=Abbasi%2C+Mojdeh&rft.date=2018-12-01&rft.pub=Springer+Nature+B.V&rft.issn=0893-7648&rft.eissn=1559-1182&rft.volume=55&rft.issue=12&rft.spage=9043&rft.epage=9056&rft_id=info:doi/10.1007%2Fs12035-018-1041-9&rft.externalDBID=HAS_PDF_LINK
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-7648&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-7648&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-7648&client=summon